Skip to content

ARGX

argenx SE

NASDAQ · Healthcare · Biotechnology · NL

$990.32
−0.55%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 22, 2026
EPS estimate
$7.27
Revenue estimate
$1.9B

Latest reported

Last report date
Jul 23, 2026
EPS actual
$7.32
EPS estimate
$6.27
Revenue actual
$2.8B
Revenue estimate
$1.6B

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+49.2%
Revenue beats (12Q)
5

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$1.2K
PT range
$932 – $1.4K
Analysts
14
13 Buy1 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 23, 2026$6.27$7.32Beat 16.75%$2.8B
May 7, 2026$6.00$5.90Miss -1.67%$2.4B
Oct 30, 2025$4.37$5.18Beat 18.54%$948.0M
May 8, 2025$0.98$2.58Beat 163.27%$1.3B
Mar 31, 2025$2.58$790.7M
Oct 31, 2024$0.10$1.39Beat 1290.00%$901.9M
Sep 30, 2024$1.39$573.2M
May 9, 2024-$0.71-$1.04Miss -46.48%$757.7M
Mar 31, 2024-$1.04$401.0M
Oct 31, 2023-$1.48-$1.25Beat 15.54%$468.2M
Sep 30, 2023-$1.25$329.8M
Jun 21, 2023$0.82-$258.0M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 4, 2027